VOYA Investment Management
CCCC icon

VOYA Investment Management’s C4 Therapeutics CCCC Stock Holding History

VOYA Investment Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,322
Closed -$27.7K – 2665
2025
Q1 		$27.7K Sell
17,322
-955
-5% -$2.85K ﹤0.01% 2601
2024
Q4 		$65.8K Sell
18,277
-1,204
-6% -$5.99K ﹤0.01% 2652
2024
Q3 		$111K Sell
19,481
-254
-1% -$1.53K ﹤0.01% 2638
2024
Q2 		$91.2K Buy
+19,735
New +$118K ﹤0.01% 2689
2023
Q2 		– Sell
-16,458
Closed -$51.7K – 2935
2023
Q1 		$51.7K Hold
16,458
– – ﹤0.01% 2796
2022
Q4 		$97.1K Hold
16,458
– – ﹤0.01% 2762
2022
Q3 		$144K Buy
16,458
+1,297
+9% +$13.5K ﹤0.01% 2693
2022
Q2 		$114K Hold
15,161
– – ﹤0.01% 2582
2022
Q1 		$368K Hold
15,161
– – ﹤0.01% 2086
2021
Q4 		$488K Buy
15,161
+297
+2% +$11.7K ﹤0.01% 2030
2021
Q3 		$664K Buy
14,864
+1,304
+10% +$55.8K ﹤0.01% 1866
2021
Q2 		$513K Buy
+13,560
New +$486K ﹤0.01% 2069

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's CCCC Position: Q2 2025 in Review

VOYA Investment Management sold out of C4 Therapeutics (CCCC) in Q2 2025, closing a stake of 17,322 shares — an estimated $27.7K sold.

VOYA Investment Management first reported a position in CCCC in Q2 2021 and held it in 12 quarters. The position peaked at $664K in Q3 2021. 102 funds tracked by Wall St. Rank hold CCCC as of Q2 2025.

  • VOYA Investment Management reported no remaining C4 Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 17,322 C4 Therapeutics shares in Q2 2025, an estimated $27.7K.
  • VOYA Investment Management first reported a position in C4 Therapeutics in Q2 2021 and held it in 12 quarters.
  • VOYA Investment Management's C4 Therapeutics position peaked at $664K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.